Amgen Inc.
US ˙ NasdaqGS ˙ US0311621009

SecurityAMGN / Amgen Inc.
InstitutionColdstream Capital Management Inc
Latest Disclosed Ownership21,717 shares
Latest Disclosed Value $ 7,641,030
Coldstream Capital Management Inc reports 30.26% increase in ownership of AMGN / Amgen Inc.

On May 8, 2026 - Coldstream Capital Management Inc filed a 13F-HR form disclosing ownership of 21,717 shares of Amgen Inc. (US:AMGN) valued at $7,641,126 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 9, 2026 disclosing 16,672 shares of Amgen Inc.. This represents a change in shares of 30.26% during the quarter. The current value of the position is $7,345,124 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-08 2026-03-31 13F AMGEN COM 031162100 21,717 5,045 30.26 7,641 40.05 0.0820
2026-02-09 2025-12-31 13F AMGEN COM 031162100 16,672 -760 -4.36 5,457 10.92 0.0703
2025-11-19 2025-09-30 13F AMGEN COM 031162100 17,432 -2,441 -12.28 4,919 -11.34 0.0662
2025-08-12 2025-06-30 13F AMGEN COM 031162100 19,873 1,985 11.10 5,549 -0.45 0.0908
2025-05-13 2025-03-31 13F AMGEN COM 031162100 17,888 1,416 8.60 5,573 29.82 0.1187
2025-02-14 2024-12-31 13F AMGEN COM 031162100 16,472 -12,174 -42.50 4,293 -53.41 0.0915
2024-11-18 2024-09-30 13F/A-1 AMGEN COM 031162100 28,646 710 2.54 9,216 5.58 0.1991
2024-11-18 2024-09-30 13F AMGEN COM 031162100 28,646 9,216
2024-08-07 2024-06-30 13F AMGEN COM 031162100 27,936 1,216 4.55 8,729 14.89 0.2127
2024-05-14 2024-03-31 13F AMGEN COM 031162100 26,720 215 0.81 7,597 -0.47 0.1929
2024-02-09 2023-12-31 13F AMGEN COM 031162100 26,505 11,839 80.72 7,634 93.68 0.2136
2023-11-02 2023-09-30 13F AMGEN COM 031162100 14,666 4,424 43.19 3,942 73.38 0.1288
2023-08-03 2023-06-30 13F AMGEN COM 031162100 10,242 -241 -2.30 2,274 -10.30 0.0720
2023-05-15 2023-03-31 13F AMGEN COM 031162100 10,483 -250 -2.33 2,534 -10.08 0.0851
2023-01-10 2022-12-31 13F AMGEN COM 031162100 10,733 -4,798 -30.89 2,819 -25.43 0.1032
2022-08-08 2022-06-30 13F/A-1 AMGEN COM 031162100 15,531 1,439 10.21 3,779 10.89 0.1472
2022-08-08 2022-06-30 13F AMGEN COM 031162100 12,165 -1,927 2,960 0.1259
2022-05-11 2022-03-31 13F AMGEN COM 031162100 14,092 1,465 11.60 3,408 19.96 0.1174
2022-02-11 2021-12-31 13F AMGEN COM 031162100 12,627 -6,577 -34.25 2,841 -41.79 0.0892
2021-11-12 2021-09-30 13F AMGEN COM 031162100 19,204 13,870 260.03 4,881 275.46 0.2366
2021-08-16 2021-06-30 13F AMGEN COM 031162100 5,334 483 9.96 1,300 7.71 0.0523
2021-06-16 2021-03-31 13F AMGEN COM 031162100 4,851 -13,195 -73.12 1,207 -70.91 0.0707
2021-02-16 2020-12-31 13F AMGEN COM 031162100 18,046 1,097 6.47 4,149 -3.69 0.2503
2020-11-16 2020-09-30 13F AMGEN COM 031162100 16,949 102 0.61 4,308 8.43 0.3586
2020-08-12 2020-06-30 13F AMGEN COM 031162100 16,847 -1,442 -7.88 3,973 7.18 0.3567
2020-05-27 2020-03-31 13F AMGEN COM 031162100 18,289 -981 -5.09 3,707 -20.19 0.4051
2020-02-13 2019-12-31 13F AMGEN COM 031162100 19,270 195 1.02 4,645 25.85 0.3809
2019-11-15 2019-09-30 13F AMGEN COM 031162100 19,075 698 3.80 3,691 9.01 0.3108
2019-08-15 2019-06-30 13F AMGEN COM 031162100 18,377 -153 -0.83 3,386 -3.81 0.2818
2019-05-10 2019-03-31 13F AMGEN COM 031162100 18,530 1,227 7.09 3,520 4.48 0.3078
2019-02-26 2018-12-31 13F AMGEN COM 031162100 17,303 427 2.53 3,369 -3.69 0.3271
2018-11-14 2018-09-30 13F AMGEN COM 031162100 16,876 723 4.48 3,498 17.34 0.3169
2018-08-14 2018-06-30 13F AMGEN COM 031162100 16,153 293 1.85 2,981 10.24 0.3012
2018-05-15 2018-03-31 13F AMGEN COM 031162100 15,860 -587 -3.57 2,704 -5.49 0.2919
2018-02-14 2017-12-31 13F AMGEN COM 031162100 16,447 519 3.26 2,861 -3.64 0.3104
2017-11-15 2017-09-30 13F AMGEN COM 031162100 15,928 970 6.48 2,969 15.26 0.3454
2017-08-14 2017-06-30 13F AMGEN COM 031162100 14,958 1,457 10.79 2,576 16.30 0.3323
2017-05-09 2017-03-31 13F AMGEN COM 031162100 13,501 154 1.15 2,215 13.53 0.3060
2017-02-09 2016-12-31 13F AMGEN COM 031162100 13,347 1,004 8.13 1,951 -5.25 0.3175
2016-11-14 2016-09-30 13F/A-2 AMGEN COM 031162100 12,343 -789 -6.01 2,059 3.05 0.3649
2016-11-14 2016-09-30 13F/A-1 AMGEN COM 031162100 12,343 -789 2,059 0.3649
2016-11-14 2016-09-30 13F AMGEN COM 031162100 12,343 -789 2,059 0.3649
2016-08-09 2016-06-30 13F AMGEN COM 031162100 13,132 -32 -0.24 1,998 1.22 0.3540
2016-05-16 2016-03-31 13F AMGEN COM 031162100 13,164 -376 -2.78 1,974 -10.19 0.3596
2016-02-04 2015-12-31 13F AMGEN COM 031162100 13,540 888 7.02 2,198 25.60 0.4773
2015-11-09 2015-09-30 13F AMGEN COM 031162100 12,652 12,652 1,750 0.4677
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.